Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has announced a series of meetings with analysts and institutional investors. These meetings are scheduled to take place from February 2, 2026, to February 4, 2026. The meetings will be conducted virtually, with one in-person meeting scheduled in Mumbai on February 3, 2026, with Kosh Wealth Management. Other virtual one-on-one meetings include those with Catamaran and Vyom Partners on February 2, 2026, and with Choice India and Avendus Spark on February 3 and February 4, 2026, respectively. The company has stated that the schedule and mode of these meetings are subject to change due to unforeseen circumstances concerning the investors, analysts, or the company itself. Rudalf Corriea, Company Secretary & Compliance Officer, signed the disclosure.
